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In previous  reports in this series, we have  described  experiments  investi- 
gating the regulation of the antibody response  to the synthetic random ter- 
polymer L-glutamic  acid6°-L-alanine~°-L-tyrosine  1°  (GAT) 1 by  an  H-2-1inked 
immune response  (Ir)  gene in vitro (1, 2). As reported for antibody responses 
elicited  in vivo (3-6)  spleen cells from both responder  (H-2 a, b, a, k)  and non- 
responder  (H-2 p, ~. ") mice develop IgG plaque-forming cells (PFC) specific for 
GAT in vitro when stimulated with GAT complexed to the carrier methylated 
bovine serum albumin (GAT-MBSA), but only spleen cells from responder mice 
develop GAT-specific IgG PFC responses to GAT. 
Using spleen cells fractionated according to their ability to adhere to plastic 
dishes the following conclusions were reached: (a) macrophages  (adherent cells) 
are required  for the responses to GAT and GAT-MBSA  in vitro; (b)  macro- 
phages  from responder  and nonresponder  mice bind GAT equally and GAT 
bound to either type of macrophage  can elicit a GAT-specific PFC response by 
nonadherent responder  lymphoid cells; and  (c)  GAT  bound to responder  or 
nonresponder  macrophages  failed  to elicit  a  GAT-specific PFC  response  by 
nonresponder  lymphoid cells. Treatment  of  spleen cells with anti-theta  (8) 
serum  and  complement (C)  before  culture  initiation abolished  responses  to 
GAT  and  GAT-MBSA,  demonstrating the  requirement for thymus-derived 
(T)  cells in the responses. Furthermore, spleen cells from GAT-primed  X-ir- 
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09897 from the National Institute of Allergy and Infectious Diseases. 
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1 Abbreviations  used  in  this  paper:  B  cell,  precursor  of  antibody-producing  cell;  GAT, 
random  terpolymer  of  L-glutamic  acid6°-L-alanine~°-r-tyrosinel°;  GAT-MBSA,  GAT com- 
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specific immune response  gene; PFC,  plaque-forming cell(s); T  cell,  thymus-derived helper 
cell; To, time of initiation; 0, surface alloantigen on T cells. 
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radiated  responder mice were  shown  to  possess  GAT-specific helper T  cells, 
while no  GAT-specific helper function could be demonstrated in spleen cells 
from  GAT-primed nonresponder mice. These data suggest that the defect in 
genetic nonresponder spleen cells is the failure of their T  cells, after interaction 
with GAT, to provide appropriate helper function for the initiation  of the B cell 
response (2). 
In the studies reported in this paper we have investigated: (a)  the effect of 
GAT on the  GAT-specific immune response to  GAT-MBSA in vivo, and (b) 
the effect of soluble GAT on the immune response to  GAT-MBSA by spleen 
cells in vitro. We have found that GAT is tolerogenic for nonresponder spleen 
cells at concentrations which are not tolerogenic, but rather immunogenic, for 
responder spleen cells. In addition, we have found that nonresponder B  cells 
are more readily tolerized by GAT than are responder B  cells. The significance 
of  these  observations with  respect  to T-B cell collaboration and the  mecha- 
nism(s) of Ir gene control of immune responses (7) will be discussed. 
Materials and Methods 
Mice.--C57BL/6J  (H-2~), SJL/J  (H-2"), and DBA/1  (H-2~) mice were purchased from 
Jackson Laboratories, Bar Harbor, Maine. B10.S (H-2*), a congenic resistant strain of mice, 
were a gift of Dr. D. Shreffier, University of Michigan, Ann Arbor, Mich. and bred in our 
animal facilities. (C57BL/6 X  SJL)F1 (H-2 hI°) mice were also bred in our animal facilities. 
These mice have the same H-2 haplotype  (H-2 hI') as F1 mice from a  C57BL/6  X  B10.S 
mating. Mice  used in these experiments were 2- to 8-mo old and were maintained  on laboratory 
chow and acidified chlorinated water ad libitum. 
Antigens.--GAT,  tool wt  32,000, was purchased  from  Miles Laboratories,  Inc., Miles 
Research Div., Kankakee, Illinois. Methylated bovine serum albumin (MBSA) was a gift of 
Dr. P. Maurer, Jefferson Medical ColIege, Philadelphia, Pa. Preparations of SRBC, GAT, and 
GAT-MBSA for addition to cultures have been described in previous papers (1). 107 SRBC, or 
GAT-MBSA containing 5 ~g GAT and/or various amounts of soluble GAT were added to cul- 
tures according to the experimental protocol. 
Immunization  of Mice.--Mice were injected intraperitoneally  with  10 ~g CAT as GAT- 
MBSA or 50 #g MBSA in a mixture of Maalox (Wm. H. Rorer, Inc., Fort Washington, Pa.) 
and pertussis vaccine (Eli Lilly & Co., Indianapolis, Ind.) as previously described (3). Mice 
were immunized with GAT according to the experimental protocol. 
Spleen Cell Cultures and PFC Assay.--Suspensions  of single spleen cells containing 10 X 10 s 
nucleated ceils in culture medium (MEM) were incubated according to the method of Mishell 
and Dutton (8) with modifications previously described (9). The hemolytic plaque assay using 
GAT-SRBC as indicator ceils has been described previously (1). 
Preparation of B  Cells.--An  attempt was made to eliminate helper T  cells from normal 
spleen cell suspensions by treatment with AKR anti-0 C3H serum and C before culture initia- 
tion (2). As a control, a fraction of the spleen cell suspension was treated with C alone. After 
treatment, 10 X 10  s cells in MEM were added to cultures with or without additional cells and 
GAT and/or GAT-MBSA according to the experimental protocol. 
Source of T Cells.--The helper cell function of antigen-primed T cells has been demonstrated 
to be radioresistant,  whereas B cells and normal T  cells are radiosensitive (10). Therefore, 
mice primed with GAT-MBSA or MBSA 1-4 mo earlier were X irradiated with 700-800 R 
as previously described (2). Within 3 h after irradiation, the mice were sacrificed and single 
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cultures  with  or without  additional  cells and  GAT  and/or  GAT-MBSA according  to  the 
experimental protocol. 
RESULTS 
Effect of GA T  on the  Immune  Response  to  GA T-MBSA  In  Vivo.--On  day 
1,  C57BL/6  (H-2*)  and  DBA/1  (H-2q)  mice  were  injected  i.p.  with  10/~g 
GAT  in  Maalox-15ertussis  or  with  Maalox-pertussis  alone.  On  day  4,  both 
normal  control  mice  and  the  primed  mice  were  injected  i÷p. with  GAT- 
MBSA,  containing  10  /~g  GAT,  in  Maalox-pertussis.  All  mice  were 
sacrified  7  days  later  and  their  spleens  examined  for  GAT-specific  IgG 
PFC  (Fig.  1).  Preinjection  of  responder  C57BL/6  mice  with  GAT  caused 
Fro. 1.  Effect  of  GAT  on  responses to  GAT-MBSA  by  responder  and  nonresponder 
mice in vivo. Normal C57BL/6 and DBA/1 mice were injected i.p. with 10 #g GAT in Maalox- 
pertussis on day 1. Three days later  these mice and normal C57BL/6 and DBA/1 mice were 
injected  i.p. with  GAT-MBSA containing  10 pg GAT in Maalox-pertussis.  7 days later  the 
mice were sacrificed and their spleens examined for IgG GAT-specific PFC. The graph shows 
the geometric mean of the PFC responses of 8-12 mice, the brackets  indicate the standard 
error of the mean. 
no  decrease  in  their  immune  responses  to  GAT-MBSA.  However,  10  vg 
GAT  caused  a  decrease  in  the  GAT-specific  immune  response  of  DBA/1 
nonresponder  mice  from  a  geometric  mean  of  7,800  PFC/spleen  to  a 
geometric mean of 620 PFC/spleen.  (200 PFC/spleen is the lowest number of 
PFC  detectable  in  this  assay.)  Although not shown,  injection  of Maalox-per- 
tussis  alone  on  day  1  caused  no  decrease  in  GAT-specific PFC  responses  to 
GAT-MBSA in either the responder or nonresponder strains of mice.  Further- 
more,  injection  of  10/~g  GAT in Maalox-pertussis  on day  1 did not decrease 
the primary immune response to SRBC injected i.p.  on day 4  in either of the 
strains of mice (not shown). Thus, we conclude that the failure of nonresponders 
to  develop  a  GAT-specific PFC  response  to  GAT  is  not  merely  a  failure  to 
recognize GAT determinants.  Quite  the contrary, nonresponder mice react to 
these determinants  and after  an encounter with  GAT, nonresponder mice are 
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MBSA. Furthermore, nonresponder DBA/1 mice were unable to develop GAT- 
specific  PFC responses when injected with GAT-MBSA as long as 5 wk after 
receiving 10 tzg GAT in Maalox-pertussis. 
Effect o/GA T; Presented in  Various Forms on the Immune Response to GA T- 
MBSA  In Vivo.--We investigated the effect of adjuvants on the induction of 
tolerance in nonresponder mice by GAT in vivo. 100 or 10 Izg GAT was injected 
i.p.  in saline,  in Maalox, or in Maalox-pertussis. Three days later,  these mice, 
as  well  as  untreated  control  mice,  were  immunized  with  GAT-MBSA  in 
Maalox-pertussis.  The  results  of a  typical experiment  are  shown in Table I. 
Regardless of the method of presentation, GAT did not decrease the anti-GAT 
response  of  C57BL/6  mice  to  GAT-MBSA.  In  nonresponder  DBA/1  mice, 
GAT in  saline  did not decrease  the  GAT-specific immune response to  GAT- 
MBSA,  whereas  100 and  10/zg GAT in Maalox with or without pertussis  did 
inhibit this response. 
Dose of GA T  in Maalox Required to Induce Tolerance  in Nonresponder Mice 
in  Vivo.--The  results  of an  experiment  in  which  DBA/1  mice were injected 
with  various amounts of  GAT in  Maalox and  subsequently  challenged with 
GAT-MBSA in  Maalox-pertussis  are  shown in Table  II. The degree of sup- 
pression  of  the  GAT-specific  immune  response  to  GAT-MBSA  is  directly 
related  to the  dose of  GAT administered.  It is  significant that  the doses  of 
GAT (100,  10, and 1.0 #g) which are tolerogenic in nonresponder mice are pre- 
TABLE I 
Effect of Adjuvants on the Induction oJ Tolerance by GA T In Vivo 
GAT 
IgG GAT-specific PFC/spleen* 
C57BL/6  DBA/1 
None  5,000  6,150 
5,400  7,000 
100 ~g in saline  5,250  3,000 
6,250  8,550 
10 #gin saline  4,800  7,200 
4,500  4,750 
100 #ginMaalox  9,500  <200 
10,400  300 
10 #gin Maalox  9,400  <200 
4,050  <200 
10 #g in Maalox -t- pertussis  11,500  600 
8,800  250 
* Mice were injected with GAT on day 1, GAT-MBSA  in Maalox-pertussis on day 4, and 
were sacrificed 7 days after injection of GAT-MBSA;  values are from individual mice. 176  GENETIC  CONTROL  OF  IMMUNE  RESPONSES  IN  VITRO 
TABLE II 
Dose of GAT Required to Induce GAT-Specific Tolerance to GAT-MBSA  in  DBA/1 Mice 
in Vivo 
Dose of GAT in Maalox at day 1  IgG GAT-specific PFC/Spleen* 
None  13,300  13,700 
100  #g  1,600  400 
10  #g  <200  800 
1.0 #g  2,000  400 
0.1 #g  9,400  13,700 
* All mice received GAT-MBSA  in Maalox on day 4 and were sacrificed 7 days later. 
Values represent PFC responses of individual mice. 
cisely those which are immunogenic in responder mice (4).  Doses of GAT of 
0.1 ~g or less are not immunogenic in responder mice (4),  and, as shown here, 
are not tolerogenic in nonresponder mice. 
Effect  of GA T  on GA T-Specific Immune Responses In  Vilro.--Next,  we ex- 
amined the effect of GAT on GAT-specific immune responses to GAT-MBSA 
in vitro. Spleen cells from normal C57BL/6 and DBA/1 mice were prepared as 
usual and cultured at 10 X  106 cells/dish. Cultures were stimulated with SRBC, 
GAT, or GAT-MBSA. Soluble  GAT in various concentrations was added  to 
other cultures with SRBC or GAT-MBSA at culture initiation.  The results of 
one experiment are presented in Table III. Soluble GAT at the highest dose, 
10 ~g/culture, had no effect on the anti-SRBC PFC responses by spleen cells 
from either of the strains of mice. As usual, there was no detectable response of 
DBA/1 spleen cells  to any dose of soluble GAT. In this experiment,  the peak 
response to soluble GAT by cultures of C57BL/6 spleen cells occurred at 1.0 ~g 
GAT/culture, whereas the higher dose (10/~g  GAT) was somewhat inhibitory. 
Both strains of mice responded to GAT-MBSA. Soluble GAT added to cultures 
of  C57BL/6  spleen  cells,  along with  GAT-MBSA,  caused  a  decrease  in  the 
GAT-specific PFC  response only at  the highest  dose  (10  /zg). However,  this 
inhibition is correlated with the observation that  10/zg GAT alone depressed 
the  optimal response to  GAT and would likewise  be  expected  to inhibit  the 
response  to  GAT-MBSA. In  contrast,  the  response  to  GAT-MBSA of  non- 
responder spleen  cells  was suppressed  by  10,  1.0, and 0.1  /~g doses  of  GAT. 
These data demonstrate that tolerance induction by GAT in nonresponder mice 
originally observed in vivo can be studied in vitro. 
Effect of GA T  on the Development  of GA T-Specific Responses to GA T-MBSA 
by Various Strains of Mice.--The ability of soluble GAT to suppress the GAT- 
specific  PFC  response developed by spleen  cells  from various strains  of mice 
stimulated with GAT-MBSA in vitro was examined. The results (Fig. 2) dem- 
onstrate that  the  GAT-specific response to  GAT-MBSA by spleen  cells  from 
other nonresponder strains of mice, SJL and B10.S mice (H-2~), like those from 
DBA/1 (H-2~) mice, are inhibited by 10 ~g soluble GAT. Spleen cells from the JUDITH  A.  KAPP,  CARL  W.  PIERCE,  AND  BARUJ  BENACERRAF  177 
TABLE III 
Effect of GA T on GA T-Specific Immune Responses In Vitro 
Strain  Antigen 
IgG PFC/culture* 
SRBC  GAT 
C57BL/6  10 #g GAT  --  235 
1.0 #g GAT  --  360 
0.1 #g GAT  --  225 
107 SRBC  130  -- 
107 SRBC +  10 #g GAT  175  -- 
GAT-MBSA  --  235 
GAT-MBSA +  10 #g GAT  --  145 
GAT-MBSA +  1.0 #g GAT  --  370 
GAT-MBSA +  0.1 #g GAT  --  255 
DBA/1  10 #g GAT  --  <20 
1.0 #g GAT  --  <20 
0.1 #g GAT  --  <20 
107 SRBC  395  -- 
107 SRBC +  10 #g GAT  385  -- 
GAT-MBSA  --  235 
GAT-MBSA +  10 #g GAT  --  50 
GAT-MBSA +  1.0 #g GAT  --  <20 
GAT-MBSA +  0.1 #g GAT  --  105 
* lO  7 C57BL/6 or DBA/1 spleen cells were cultured. 
responder  (C57BL/6  X  SJL)F1 mice, like those from  C57BL/6 mice, are not 
rendered tolerant by 10 #g soluble GAT. 
Sensitivity of Spleen Cells to  Tolerance Induction  as a Function  of Time after 
Culture Initiation.--Cultures of spleen cells from normal C57BL/6 and DBA/1 
mice were prepared and  GAT-MBSA was added  to all cultures at the time of 
initiation  (To).  At To or at  24-h  intervals thereafter,  soluble GAT  (5  #g)  was 
added to these cultures. After 5 days, cultures were harvested and examined for 
GAT-specific  PFC  responses;  a  typical  experiment  is  shown  in  Table  IV. 
Addition of soluble GAT at any time did not significantly inhibit the anti-GAT 
response to  GAT-MBSA by responder spleen cells.  Soluble GAT added at To, 
24,  or 48  h  significantly inhibited  the  development of the  GAT-specific PFC 
responses to GAT-MBSA by spleen cells from nonresponder mice, although the 
inhibition at 48 h  was not as profound as that caused by addition of GAT at 
To or 24 h. Addition of GAT at 72 h  or later had no effect on the GAT-specific 
PFC response developed by these cultures, indicating that GAT interferes with 
an  early  event  in  the  initiation  of  the  GAT-specific  antibody  response  to 
GAT-MBSA. 
Other  cultures  of  these  spleen  cells  were  stimulated  with  GAT-MBSA or 
GAT-MBSA plus soluble GAT (5  ~g)  at culture initiation, harvested at 24 or 
48  h,  washed  three  times  in  sterile  MEM,  and  collected by  centrifugation. 178  GENETIC  CONTROL  OF  IMMUNE  RESPONSES  IN  VITRO 
Fro. 2.  Effect  of  GAT on responses to  GAT-MBSA by  spleen cells from  responder  and 
nonresponder mice in vitro,  l0  T spleen cells from normal_responder or nonresponder mice were 
cultured with  10 #g GAT or GAT-MBSA containing 5 #g GAT or both and PFC  responses 
determined on day 5. 
Cells harvested from three cultures were plated out in two dishes. These cultures 
received no further antigen. However, it is important to note that soluble GAT 
is removed from the cultured  cells by several washes, whereas the particulate 
GAT-MBSA is not removed from washed spleen cells.  The results (Table IV) 
show that if GAT is removed from culture after 24 h, the anti-GAT response to 
GAT-MBSA is only partially inhibited in cultures of nonresponder spleen cells. 
By comparison, the GAT-specific response to GAT-MBSA by cultures  of non- 
responder spleen cells incubated with GAT for 48 h was profoundly depressed. 
Since contact with GAT for 24 h  does not abrogate the anti-GAT response to 
GAT-MBSA, we feel that the effects of GAT are not irreversible at that early 
time. Whether the depressed response which occurs after incubation with GAT 
for 48 h  means that the inhibition is irreversible after more prolonged contact 
with  GAT or  that  the  response  to  GAT-MBSA is delayed  in  these  cultures, 
and occurs later than the usual 5-day peak response, cannot be determined from 
these data. Detailed studies of the kinetics of such responses during the 5 days 
after termination of exposure to GAT should clarify this point. 
Greater Susceptibility  of Nonresponder  B  Cells  than  of Responder  B  Cells  to 
Tolerance  Induction  by GAT.--In  previous reports from this laboratory (11), 
Katz et al.  have shown,  using a  double adoptive cell  transfer system in vivo, 
that T  cells from F1 hybrid mice cooperate with B  cells from either parental 
strain in  the development of immune responses to conventional antigens such 
as keyhole limpet hemocyanin. In contrast, if the response to the carrier moiety 
of the antigen is under Ir gene control, carrier-primed T  cells from (responder X JUDITH  A.  KAPP,  CARL  W.  PIERCE,  AND  BARUJ  BENACERRAF  179 
TABLE  IV 
Effect of Addition of GA T  at  Various Times to Cultures Stimulated by GA T-MBSA 
Time 5 #g GAT added 
IgG GAT-specific PFC/culture* 
C57BL/6  DBA/1 
No GATadded  765  1,685 
To  1,050  <10 
24 h  650  80 
48 h  895  810 
72 h  880  1,150 
96 h  665  1,725 
Cells washed at 24 h 
No GAT  810  2,435 
GAT at To  1,285  1,770 
Cells washed at 48 h 
No GAT  585  1,630 
GAT at To  1,175  100 
* l0  T C57BL/6 or DBA/1 spleen cells were cultured. 
nonresponder)F1 mice provide effective helper function only to the responder 
parental B  cells (12). As shown in Fig. 3 and in the accompanying paper (13), 
irradiated  GAT-MBSA-primed  (C57BL/6  X  SJL)Ft  T  cells  cooperate  with 
both responder and nonresponder parental B  cells in cultures stimulated with 
GAT-MBSA.  However,  when  incubated  with  soluble  GAT,  these  F1 T  cells 
provide effective helper function only to the responder parental B  cells.  Addi- 
tion  of soluble  GAT to  cultures  containing  Ft  T  cells,  parental  B  cells,  and 
GAT-MBSA (Fig. 3) suppresses the GAT-specific responses of the nonresponder 
parental B cells but not those of the responder parental B cells. 
It has been demonstrated that B cells are more readily rendered unresponsive 
by antigens in the absence of specific helper T  cells (14,  15). Thus, it is possible 
to argue that the nonresponder B cells in the previous experiment were rendered 
tolerant to GAT while responder B  cells were not, since the responder B  cells 
were influenced by GAT-specific helper cell activity from the F~ T  cells, whereas 
nonresponder B  cells may be influenced only by MBSA helper T-cell activity. 
In an attempt to determine if a  real difference in the ability of responder and 
nonresponder B  cells to be tolerized exists, the following experiment was per- 
formed.  Anti-0  and  C-treated  responder  B  cells,  were  cultured  with  GAT- 
MBSA-primed or MBSA-primed X-irradiated  C57BL/6  cells.  It can be seen 
in Table V that GAT-MBSA-primed T cells provided the necessary helper func- 
tion to B  cells for the development of GAT-specific responses to GAT-MBSA 
and  GAT.  Furthermore,  soluble  GAT did  not  inhibit  the  response to  GAT- 
MBSA or to GAT, but in fact, increased the response when 10/zg of GAT was 
added.  Cultures of MBSA-primed T  cells and C57BL/6 B  cells also developed 180  GENETIC  CONTROL OF  IMMUNE RESPONSES  IN  VITRO 
FIG. 3.  Effect of  GAT  on  responses to  GAT-MBSA in  cultures of responder and  non- 
responder B  cells  containing GAT-MBSA-primed irradiated  F1  spleen cells.  Soluble  GAT 
(10/zg) or GAT-MBSA containing 5/zg of GAT or both were added to cultures containing 
10 X  106 C-treated spleen cells from normal C57BL/6 or B10.S mice and to cultures contain- 
ing 10  X  106 B  cells (anti-0 -b  C-treated spleen cells)  plus 10  X  106  GAT MBSA-primed 
irradiated (C57BL/6 X  SJL)F1 spleen (T)  cells. Controls demonstrate that cultures of 10 X 
106 B cells or 10  X  106 GAT-MBSA-primed irradiated T  cells alone were unable to develop 
GAT-specific PFC responses. 
a  GAT-specific PFC response to GAT-MBSA. However, no GAT-specific PFC 
response was detected  in  these  cultures  when incubated  with  GAT.  Further- 
more, addition of soluble GAT to cultures stimulated by GAT-MBSA did not 
interfere with the GAT-specific PFC response. Thus, in the absence of detecta- 
ble GAT-specific helper T-cell function,  B  cells from responder mice were not 
rendered unresponsive by soluble GAT. 
DISCUSSION 
Nonresponder H-2" and H-D-mice fail to develop immune responses to GAT 
but nevertheless may be stimulated to form anti-GAT antibodies by immuni- 
zation with  GAT bound to an immunogenic carrier such as MBSA for which 
helper T-cell function  can  be generated  (1-5).  Furthermore,  as shown in  the 
experiments  presented  in  this  paper,  administration  of  GAT  renders  nonre- 
sponder mice unable to develop GAT-specific PFC  responses to a  subsequent 
challenge with GAT-MBSA. The addition of soluble GAT, together with GAT- 
MBSA, to spleen cell cultures from nonresponder strains of mice abolishes anti- 
GAT responses.  GAT is,  therefore, tolerogenic in vivo and in vitro for nonre- JUDITH  A.  KAPP~ CARL  W.  PIERCE~  AND  BARI3J  BENACERRAF  181 
TABLE V 
Failure of GA T  to Suppress  GA T-Specific PFC Responses to  GA T-MBSA  by Responder B 
Cells in the Absence of GAT-Specific  Helper  T Cells 
l0 T  Anti-e and 
IgG GAT-Specific  C-treated  10T X-irradiated C57BL/6  Antigen 
C57BL/6 spleen  cells primed to:  PFC/Culture 
cells 
+  --  1.0 #g GAT  0 
+  --  GAT-MBSA  0 
-  GAT-MBSA  GAT-MBSA  0 
+  GAT-MBSA  10 #g GAT  440 
+  GAT-MBSA  1.0 #g GAT  375 
+  GAT-MBSA  0.1 #g GAT  95 
+  GAT-MBSA  GAT-MBSA  435 
+  GAT-MBSA  GAT-MBSA +  10 #g GAT  590 
+  GAT-MBSA  GAT-MBSA +  1.0/~g GAT  440 
+  GAT-MBSA  GAT-MBSA +  0.1 #g  GAT  380 
--  MBSA  GAT-MBSA  0 
+  MBSA  10 #g GAT  0 
+  MBSA  1.0 #g GAT  0 
+  MBSA  0.1 #g GAT  0 
+  MBSA  GAT-MBSA  410 
+  MBSA  GAT-MBSA +  10/~g GAT  395 
+  MBSA  GAT-MBSA +  1.0 #g GAT  355 
+  MBSA  GAT-MBSA +  0.1 #g GAT  320 
sponder  cells  under  conditions  where  immunity  is  elicited  in responder  cells. 
Certain critical aspects of the tolerogenic properties of GAT for nonresponder 
mice are  particularly  informative:  (a)  The minimal  dose of GAT required to 
induce tolerance in nonresponder mice is precisely the dose required to stimulate 
immunity in responder mice.  (b)  GAT behaves as a  tolerogen in vivo for non- 
responder mice,  even when administered  with  a  strong adjuvant  such as per- 
tussis  vaccine.  (c)  Unresponsiveness  to  GAT  is  a  long-lasting  phenomenon; 
spleen cells from GAT-treated nonresponder mice were shown to remain unre- 
sponsive for as long as 5 wk after a doseof 10 #gof GAT, although this is a readily 
metabolized polypeptide.  (d) The tolerogenic effect in vitro is induced between 
24 and 72 h after culture initiation which is also the critical time when immuno- 
competent cells become irreversibly committed to respond to antigen (16). 
How can the tolerogenic properties of GAT for nonresponder spleen cells be 
explained  when  all the parameters of this phenomenon listed  above are taken 
into  account?  Several  possible  mechanisms  can  be  evoked which  are  not  all 
necessarily  mutually  exclusive:  (a)  The  remarkable  susceptibility  of  nonre- 
sponder  animals  to  tolerance  induction  by  GAT  reflects  fundamental  differ- 
ences in B  cells of responder  and  nonresponder animals  in their  ability  to be 
rendered unresponsive by this polypeptide. The finding that responder, in con- 
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(responder  X  nonresponder)F1  helper  T  cells  develop  a  response  to  GAT- 
MBSA which is not inhibited by soluble GAT favors this interpretation. This 
hypothesis, however, would imply the functional expression of the Ir gene in 
B cells as well as in T  cells and would also lead to the conclusion that Ir genes 
are not clonally expressed in these cells. The nondonal expression of Ir gene 
products in immunocompetent cells is difficult to reconcile with the remarkable 
specificity of the recognition controlled by these genes (7). 
(b)  There are no differences in responder and nonresponder B  cells in their 
ability to bind or respond to GAT. The increased susceptibility of nonresponder 
spleen cells to tolerance induction could be explained by the absence of GAT- 
specific helper T-cell function. It has indeed been shown that spleen cells in the 
absence of activated helper T  cells are easily tolerized (14,  15). We have also 
shown that  GAT-specific helper function cannot be  demonstrated in nonre- 
sponder mice immunized with GAT. In the absence of helper function for GAT, 
GAT-specific B  cells would be expected to become specifically tolerant. This 
interpretation postulates the expression of the Ir gene in T cells to the exclusion 
of B cells and implies that the Ir gene product/unctions as a receptor molecule 
of T  cells as proposed earlier (7). 
The first two hypotheses are not easily reconciled, however, with the long- 
lasting  tolerance  observed  after  relatively low  doses  (10  /~g) of  the  readily 
metabolizable  GAT. They would require  that nonresponder  GAT-specific B 
cells remain unresponsive to GAT-MBSA in the presence of MBSA-primed syn- 
geneie T  cells several weeks after tolerance induction. This possibility is cur- 
rently being investigated. 
(c)  Our data could also be explained by the hypothesis suggested earlier by 
Gershon  et  al.  (6)  that  genetic nonresponders do not  develop  GAT-specific 
helper T  cells, but develop only suppressor T  cells in  response to GAT. This 
would imply that the Ir gene product could be restricted to a certain class of 
T  cells  concerned with helper  function where  they could behave  as antigen 
receptors. These T  cells would be lacking in nonresponder animals. According 
to this interpretation, the function of the Ir gene product would be crucial in 
the development of tolerance vs. immunity. The system we have developed to 
analyze the anti-GAT response of fractionated spleen cells from nonresponder 
animals to  GAT-MBSA  at various times after tolerance induction by  GAT 
should permit a choice between these various possibilities presented and thus a 
better understanding of the precise function of the Ir gene product in immuno- 
competent cells. 
SUGARY 
Although nonresponder,  H-2  s and//-2  ~, mice fail to develop  GAT-specific 
PFC responses to GAT, they do develop GAT-specific PFC responseswhen stim- 
ulated by GAT complexed to an immunogenic carrier such as methylated bovine 
serum albumin. The studies described in this paper show that injection of non- JUDITH A.  KAPP, CARL W.  PIERCE,  AND BARUJ BENACERRAF  183 
responder  mice with  GAT specifically decreases  their  ability  to develop  anti- 
GAT PFC responses to a subsequent  challenge with GAT-MBSA. Addition of 
GAT to cultures of spleen cells from nonresponder mice also prevents develop- 
ment  of the  GAT-specific PFC  responses  stimulated  by  GAT-MBSA. Thus, 
interaction of nonresponder spleen cells with GAT leads to the induction of un- 
responsiveness in vivo and in vitro. 
Various  parameters  of the  tolerance  induction  have  been  investigated  and 
described.  A  comparison of the effects of GAT on B  cells indicates that nonre- 
sponder B  cells are more readily rendered  unresponsive  by soluble  GAT than 
are responder B  cells.  The significance of these data for our understanding  of 
Ir gene regulation of the immune response is discussed. 
We thank Ms. Fern De La Croix for her excellent technical assistance in these studies. 
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